303 related articles for article (PubMed ID: 8973472)
1. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
Toma L; Dietrich CP; Nader HB
Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
[TBL] [Abstract][Full Text] [Related]
2. Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins.
Dietrich CP; Tersariol IL; Toma L; Moraes CT; Porcionatto MA; Oliveira FW; Nader HB
Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):417-29. PubMed ID: 9620437
[TBL] [Abstract][Full Text] [Related]
3. Molecular size difference of urinary heparan sulfates from normal individuals and genetic mucopolysaccharidoses.
Taniguchi N; Miyawaki T; Moriya N; Okuda N
Clin Chim Acta; 1975 May; 60(3):363-9. PubMed ID: 124636
[TBL] [Abstract][Full Text] [Related]
4. A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates.
Fuller M; Chau A; Nowak RC; Hopwood JJ; Meikle PJ
Glycobiology; 2006 Apr; 16(4):318-25. PubMed ID: 16377754
[TBL] [Abstract][Full Text] [Related]
5. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
Zhang H; Wood T; Young SP; Millington DS
Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
[TBL] [Abstract][Full Text] [Related]
6. Structure of heparan sulfate from the fresh water mollusc Anomantidae sp: sequencing of its disaccharide units.
Ferreira TM; Medeiros MG; Dietrich CP; Nader HB
Int J Biochem; 1993 Sep; 25(9):1219-25. PubMed ID: 8224365
[TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
8. On the structure of heparitin sulfates. Analyses of the products formed from heparitin sulfates by two heparitinases and a heparinase from Flavobacterium heparinum.
Silva M; Dietrich CP; Nader HB
Biochim Biophys Acta; 1976 Jun; 437(1):129-41. PubMed ID: 132967
[TBL] [Abstract][Full Text] [Related]
9. Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy.
Nader HB; Porcionatto MA; Tersariol IL; Pinhal MA; Oliveira FW; Moraes CT; Dietrich CP
J Biol Chem; 1990 Oct; 265(28):16807-13. PubMed ID: 2211596
[TBL] [Abstract][Full Text] [Related]
10. Sanfilippo's syndrome type C--the first known case in South Africa.
Petersen EM
S Afr Med J; 1986 Jan; 69(1):63-8. PubMed ID: 3079922
[TBL] [Abstract][Full Text] [Related]
11. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP
Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695
[TBL] [Abstract][Full Text] [Related]
12. Anomalous structure of urinary chondroitin sulfate from cancer patients. A potential new marker for diagnosis of neoplasias.
Dietrich CP; Martins JR; Sampaio LO; Nader HB
Lab Invest; 1993 Apr; 68(4):439-45. PubMed ID: 8479152
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
Volpi N; Maccari F
Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
[TBL] [Abstract][Full Text] [Related]
15. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
Volpi N
Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
[TBL] [Abstract][Full Text] [Related]
16. Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates.
Sugahara K; Tohno-oka R; Yamada S; Khoo KH; Morris HR; Dell A
Glycobiology; 1994 Aug; 4(4):535-44. PubMed ID: 7827415
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of N-acetylglucosamine 6-sulfate from the urine of a patient with Sanfilippo type D syndrome and its occurrence in normal urine.
Hopwood JJ; Elliott H
Biochem Int; 1983 Jun; 6(6):831-6. PubMed ID: 6435628
[TBL] [Abstract][Full Text] [Related]
18. Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.
Dean MF; Stevens RL; Muir H; Benson PF; Button LR; Anderson RL; Boylston A; Mowbray J
J Clin Invest; 1979 Jan; 63(1):138-46. PubMed ID: 105013
[TBL] [Abstract][Full Text] [Related]
19. Chemical definition of the mucopolysaccharidoses.
Constantopoulos G; Dekaban AS
Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832
[TBL] [Abstract][Full Text] [Related]
20. Keratan and herparan sulfaturia: glucosamine-6-sulfate deficiency.
Matalon R; Wappner R; Deanching M; Brandt IK; Horwitz A
Ann Clin Lab Sci; 1982; 12(3):234-8. PubMed ID: 6212020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
